Friday, June 05, 2026

 

How peach fuzz could hold clues to develop new treatments for chronic itch



Researchers discover specialized neurons and vellus-like hair in mice—hairs that are like vellus hairs, or peach fuzz, on humans—give rise to itchiness in response to touch




University of Michigan





Working with mouse models, research led by the University of Michigan has revealed previously hidden biology of how touch-sensitive hairs create itching sensations. This fundamental discovery opens new avenues to better understand and potentially address human health conditions characterized by persistent itchiness. 

"Itch is one of the major symptoms in most chronic skin inflammation patients," said Bo Duan, associate professor in the Department of Molecular, Cellular, and Developmental Biology. "What we've discovered is a pathway that we believe plays a very important role for both acute and chronic itch sensation."

The team discovered a previously unrecognized class of hairs in mice, known as vellus-like hairs, and a specialized population of touch-sensitive neurons that connect to them. As their name suggests, these hairs are similar to the fine, short, light-colored vellus hairs found on humans, though we more commonly refer to them as peach fuzz.

The work, supported in part by funding from the National Institutes of Health, was published in the journal Neuron.

For one set of experiments, the team worked with mice that had chronic skin inflammation, which is known as eczema in humans. Mice that expressed these neurons scratched normally, as one would expect. But, for mice that lacked those neurons or in which the neurons were inactive, the itching response was greatly reduced.

While there are a number of ways to help soothe chemical itch caused by things like mosquito bites and poison ivy, those treatments are ineffective against itch caused by skin inflammation, Duan said. This study suggests treatments that target the "mechanical itch" pathway could be more successful.

"We need a new pathway to target if we want to treat chronic itch," Duan said. "And our research suggests that this population of neurons could be a target in the future. We have ongoing projects looking at this."

Although the team can't run experiments to directly identify the same or related pathways in humans, the researchers are already building the case with other forms of evidence. For starters, humans do possess genes required to make these touch-sensitive neurons. 

The team also discovered proteins in mice that help transmit the itch signal from hairs to the spinal cord via the specialized neurons. Human neurons grown in cultures respond to the same proteins, the team found.

"Our study indicates that humans may have this same kind of mechanism to transmit mechanical itch," Duan said. "It also reveals that the body has a dedicated system for this type of sensation."

A real head-scratcher

It's one of Duan's favorite science demonstrations, one that he gave while interviewing for his job and one that he still shows to students joining his lab.

First, you take a tissue and roll one of its corners into a long, fine point. Then take that point and, ever so gently, stroke at the hairs around your lips. Not the thicker, darker hairs, which are called terminal hairs, but the thin, light vellus hairs. If you graze one just right, that peach fuzz will make you itch.

"Humans and animals experience this kind of itch, but no one knew the molecular and cellular mechanisms behind it," Duan said. The new study identifies the sensory pathway that links specialized hairs to itch and, together with earlier research from Duan and his teammates, helps explain how these signals are transmitted through the nervous system.

It was more than a century ago that scientists first noted that the vellus-like hairs of mice, which are especially concentrated behind their ears, beneath their lips and at the base of their paws, were "special." Yet these hairs have remained largely understudied in sensory science, Duan said.

Because of that, there really weren't any standard procedures to test whether and how mice responded to mechanical itch. That meant Duan and his colleagues had to develop their own methods.

"A mouse can't say that it's itchy," Duan said. "But it will scratch."

For the new study, the team mechanically stimulated itch in mice using a small loop of thread and stroking the animal's vellus-like hairs. Once they identified the neurons that gave rise to the itching response, the researchers could then make those neurons sensitive to blue light. Shining light on a mouse's skin and observing it scratch in the same way it did with mechanical stimulation helped confirm the specific neurons' role in itch.

Peach fuzz and peach fuzz-like hairs grow in higher numbers near human and mice mouths and ears, Duan said. This suggests they may have evolved as a warning system for mammals to alert them when pests or parasites are trying to get in.

But human bodies are covered in vellus hair (with some notable exceptions like the palms of our hands) and you may wonder why we're not constantly scratching if we're coated with such sensitive touch receptors. Another one of Duan's earlier projects studying itch in mice could also explain that: Within the spinal cord, there are "gating" circuits at work that essentially block the mechanical itch signal unless it's activated in a particular way.

 

Researchers find older adults rarely discuss cannabis use with clinicians



Most older adults report that they don’t receive drug screenings, according to a Rutgers Health study



Rutgers University




Fewer than one in five adults older than 65 report discussing their cannabis use with clinicians, according to Rutgers Health researchers.

 

Their study, published online ahead of print in the August 2026 issue of the American Journal of Preventive Medicine, explored the prevalence of conversations between patients and clinicians about cannabis use and its potential harms.

 

Research shows an increase in the number of older adults who use cannabis, with 10.5% of adults older than 65 reporting using cannabis in the past year, according to reports from the 2024 National Survey on Drug Use and Health.

 

“Cannabis use is on the rise; therefore it’s crucial for physicians to facilitate important conversations about the potential consequences of cannabis, especially for older adults and those with chronic diseases,” said Pia Mauro, a core member of the Center for Pharmacoepidemiology and Treatment Science at the Rutgers Institute for Health, Health Care Policy and Aging Research and lead author of the study.

 

Using nationally representative data derived from more than 14,000 older adults, Rutgers Health researchers analyzed reports of cannabis and other drug use, whether patients were screened for drug use and whether they had conversations with their clinicians about their drug use.

 

One in three older adults in the study reported being screened for cannabis or drug use by a clinician in the past year. Fewer than one in five older adults who used cannabis recreationally or medicinally reported discussing their use with a clinician.

 

Rutgers researchers warn that older adults need to understand cannabis use risks because aging and higher rates of chronic conditions make them more susceptible to harmful effects. But past research has reported that some clinicians feel confusion or discomfort discussing cannabis use with patients, and some desire more education on the medical use of cannabis.

 

“Screenings for cannabis use, which are available to clinicians and easy to implement, should be part of routine medical care for all older adults,” said Mauro, who is also an associate professor of epidemiology at the Rutgers School of Public Health. “Physicians can use single-item screening questions to facilitate conversations about cannabis use during a routine visit.”

 

The data showed even lower rates of cannabis use screenings and discussions reported by older women and older Hispanic or Latine populations. Researchers said these findings could be attributed to less frequent use of cannabis by women and systemic barriers facing marginalized populations.

 

In addition to further research on gender and racial gaps, researchers recommend conducting studies that incorporate restricted data with geographic information, which would allow findings to be analyzed within the context of varying state-level recreational cannabis laws.

 

Coauthors of the study include Mireia Triguero Roura of the Institute for Health, Health Care Policy and Aging Research, Elsa Carey of the Columbia University Mailman School of Public Health and Benjamin Han of the University of California San Diego. The research was supported by multiple grants from the National Institute on Drug Abuse.

 

Safe firearm storage may reduce pediatric lead exposure in households with guns



A new study led by epidemiologists at Brown University found that among firearm owners, less safe storage was associated with higher blood lead levels in children



Peer-Reviewed Publication

Brown UniversityFacebook












PROVIDENCE, R.I. [Brown University] — In homes with guns, proper storage is important in preventing injuries and deaths. Now, researchers have found a secondary benefit: Gun owners may be able to minimize children’s exposure to lead, an environmental toxin, by safely storing their firearms and ammunition.

“Keeping guns away from children is an important factor in reducing the amount of lead those children are exposed to,” said lead study author Christian Hoover, a pre-doctoral fellow in epidemiology at Brown University’s School of Public Health.

The findings were published in the Journal of Exposure Science and Environmental Epidemiology.

Hoover’s research has focused on how firearm-related lead can contribute to increased blood lead levels in children in the United States. Firearms use lead-based ammunition and primers, he explained, so discharging a firearm releases lead particles that can be inhaled or inadvertently transported into the home on contaminated clothing or gear.

To examine the relationship between firearm storage and children’s blood lead levels, Hoover collaborated with Joseph Braun, a professor of epidemiology at Brown who studies the health effects of environmental pollutant exposures on babies, children and adolescents. Their previous research found an association between household firearm ownership and elevated lead levels in children’s blood in 44 states, and in this study, they wanted to focus on individuals.

The research team analyzed data from the longitudinal HOME Study, which was developed to assess the effects of environmental toxicant exposures on various health outcomes. The study, based in Cincinnati, Ohio, enrolled over 400 pregnant women from 2003 to 2006 and is following them and their babies over time.

In the HOME Study, blood lead levels were measured at ages 12, 24 and 36 months and floor dust lead levels from first measurement, at 12 and at 24 months. Caregivers reported firearm ownership, number of firearms and storage practices during pregnancy.

The team’s analysis found that in homes where firearms were not stored or locked, there was 29% to 84% higher dust lead from first measurement through when the child was 24 months of age, and children had approximately 20% higher blood lead levels at ages 12 to 36 months.

“Lead is a known neurotoxicant, and there is no safe level of exposure for young children,” said Braun, who directs the Center for Climate, Environment and Health at Brown. “Early lead exposure can increase the risk of cognitive and behavior problems in childhood, and potentially criminal behavior in adulthood.”

Young children are particularly vulnerable to lead because they spend more time on the floor, where dust collects, and tend to put lead-contaminated objects (or their hands) in their mouths. 

“These data show that it is important to consider multiple sources of environmental lead exposure to protect children’s rapidly developing and sensitive brains,” Braun said.

Hoover added that working alongside gun owners is essential as researchers continue to study the connections between firearm use and pediatric lead exposure.

“Most gun owners are safety oriented and thoughtfully engaged in determining how to prevent firearm-related harms, and these findings present an actionable way to address lead exposure,” Hoover said.

This work was funded by the National Institutes of Environmental Health Sciences (F31 ES036867, P01 ES011261, R01 ES014575).

 

Randomized controlled trials have limits when informing the effects of ultraprocessed foods



Summary author: Meagan Phelan


American Association for the Advancement of Science (AAAS)





Though several randomized controlled trials have investigated the effects of ultraprocessed foods (UPF) on obesity, leading to news coverage that suggests ultraprocessing is inherently harmful, the reality is different, according to the authors of this Perspective. Based on the design of clinical trials conducted to date, it is very difficult to attribute negative effects observed in trial participants to ultraprocessing. Instead, these effects are likely due to differences in traditional nutritional properties that UPFs frequently exhibit – including soft textures (which can lead people to eat more and faster), high calorie density, high amounts of saturated fat and salt, and low fiber and protein content. These properties affect health regardless of the extent of food processing, Faidon Magkos and colleagues say. The authors describe the five clinical trials conducted so far on UPFs in the USA, UK, Denmark, and Japan, outlining the trials’ methods, variable findings, and limitations. “Collectively, available randomized controlled trials provide weak support for an ultraprocessing-specific effect of UPFs on body weight regulation and cardiometabolic function that is independent of established nutritional determinants,” Magkos et al. write. They note that the UPF concept encompasses many foods that are unhealthy, but also foods that are not necessarily harmful and even some that are beneficial. Based on evidence from the trials, they recommend that policy guidance around UPFs should focus on distinguishing nutritionally poor, calorie-dense, and rapidly consumed foods – regardless of their degree of processing.

 

Podcast: A segment of Science's weekly podcast with Faidon Magkos, related to this research, will be available on the Science.org podcast landing page after the embargo lifts. Reporters are free to make use of the segments for broadcast purposes and/or quote from them – with appropriate attribution (i.e., cite "Science podcast"). Please note that the file itself should not be posted to any other Web site.

 

Being “half-included” in American society takes a toll on immigrant health, study finds



Acculturative discordance – the state of being socially integrated on some dimensions but not on others – is associated with high disability risks after age 65




University of Toronto





Toronto, ON – There is a well-documented puzzle in social epidemiology: immigrants have better health than the native-born when they first arrive, but they lose this advantage at older ages. Is acculturation to blame – the process by which immigrants adopt the culture and behavior of their new country?

Although this is a popular hypothesis, a new study published in the Journal of Health and Social Behavior tells a different story. If anything, acculturation appears to protect health: older U.S. immigrants who speak English well have 40 to 50 per cent lower odds of having a disability than those who don’t. Having a U.S.-born spouse, a marker of social adaptation, is linked with 10 to 20 per cent lower odds of disability than having a foreign-born spouse.

However, when immigrants are acculturated on some dimensions but not on others – an experience called “acculturative discordance” – they have worse health. For example, being married to a U.S.-born spouse but not speaking English well predicts higher risks of ambulatory disability than having a foreign-born spouse and limited English proficiency. Ambulatory disability, including difficulties with walking or climbing, is the most prevalent disability in the U.S. and affects one in four adults aged 65 and older.

“Some immigrants behave and feel very much like Americans, yet they get perceived as foreigners because they don’t sound like the average American or they live in an immigrant enclave,” says Leafia Ye, assistant professor of sociology at the University of Toronto and author of the study. “The results indicate that this discordance can be physically stressful – and show up as disability in later life.”

The study was based on the American Community Survey, a large population survey collected by the U.S. Census Bureau. It contained 958,211 immigrants aged 65 to 80.

Another key finding is that acculturation protects health more for white immigrants than for Black, Hispanic and Asian immigrants. As a result, highly acculturated white immigrants can retain their health advantage over the U.S.-born at older ages, but minoritized immigrants lose their advantage.

“Racially minoritized immigrants experience another layer of discordance – as they adapt more to U.S. society, they might also confront more racial discrimination and exclusion. This discordance helps explain the racial disparities in health as immigrants get older,” says Ye, who is also an affiliate faculty member with the Institute for Life Course & Aging and the Global Migration Lab at the Munk School of Global Affairs & Public Policy.

“This study highlights that being ‘half-included’ is a tough experience – you are blending in more, but you might also be hitting a wall. It is not the immigrant experience that people typically imagine, so it too often gets ignored – but shouldn’t.”

-30-

 

Time for a re-think of long-term antidepressant use





Adelaide University

Associate Professor Mark Horowitz 

audio: 

Associate Professor Mark Horowitz speaks about long-term use of antidepressants.

view more 

Credit: Associate Professor Mark Horowitz, Adelaide University.





Fresh concerns have been raised over long-term use of antidepressants, with a new summary of evidence revealing limited benefits and higher health risks, prompting calls for treatment reviews every six months.

Researchers from Adelaide University and The University of Queensland were involved in the clinical overview, which has been published in the Australian Journal of General Practice.

They found there was little robust evidence to suggest that antidepressants prevent relapse beyond 12 months and believe the widely cited benefits supporting long-term use may be overstated due to a fundamental flaw in research design.

“Much of the evidence supporting long-term antidepressant treatment comes from so-called relapse prevention trials,” said Associate Professor of Psychiatry Mark Horowitz, at Adelaide University’s School of Medicine.

“These studies typically compare patients who continue medication with those who stop abruptly or rapidly. Because they don’t distinguish between withdrawal symptoms and the return of depression, we believe many apparent relapses may actually be withdrawal effects from the medication.”

Short-term trials of antidepressants reveal only small differences in improvements when compared to a placebo. There was also some research indicating that the apparent benefit of long-term treatment may be due to the suppression of withdrawal symptoms rather than the true prevention of depression or anxiety.

The research also highlights growing evidence of risks associated with long-term use, including sexual dysfunction, emotional numbing, cognitive impairment, weight gain and increased risk of physical health problems in older adults.

Withdrawal symptoms can be severe and long-lasting, sometimes persisting for months or even years.

“Symptoms such as anxiety, low mood and insomnia occur in both withdrawal from antidepressants and a return of depression. As these studies do not distinguish between them, they will mis-categorise withdrawal as a return of depression as this is the focus of such studies,” said Associate Professor Horowitz.

“If the same approach was taken with cigarettes and feeling worse on stopping them was interpreted as evidence that people should continue smoking them, we know that would be absurd. But the same sort of evidence is used to recommend long-term antidepressants.

“Guidelines need to be updated to reflect that there are no good studies which show that antidepressants are effective in the long term.” 

Nearly one in seven Australians are taking antidepressants, with a third of people staying on them for more than a year. Most of this medication is being prescribed by general practitioners, often in situations where guideline criteria may not be fully met.

“Concerningly, the risk of withdrawal effects appears to increase with the duration of use – one reason for stopping antidepressants sooner rather than later,” said Associate Professor Horowitz.

Researchers say many patients recover from depression without long-term medication and are calling for a re-think of how depression is treated long-term, noting that non-drug approaches such as psychological therapies may offer more durable benefits. 

“As GPs, we are becoming more aware of the limited benefits and possible harms associated with long-term antidepressant use and the need to reconsider the ‘set and forget’ approach to prescribing these medicines,” said Professor Katharine Wallis, Head of General Practice at The University of Queensland Medical School.

“There is increasing emphasis on supporting patients to make informed choices about antidepressant use and to stop antidepressants by slowly decreasing the dose.”

 Other recommendations include addressing misconceptions about depression being caused by a ‘chemical imbalance’, recognition that worsening symptoms on stopping antidepressants may be linked to withdrawal rather than relapse and wider adoption of gradual weaning strategies when discontinuing medication for long-term users.